Kingsley Leung

Co-founder and Chairman, Great Bay Bio

 

For making medicines better

Credit Suisse

In 2019, Kingsley Leung, chairman of traditional pharmaceutical R&D company Uni-Bio Science Group, spotted an opportunity to use AI and robotics to dramatically improve the drug development process. As a result, he spun off a new company, Great Bay Bio, which makes developing new medicines faster and more efficient, potentially reducing both the time it takes and the risks of the process by half.

ADVERTISEMENT - CONTENT CONTINUES BELOW

Recognitions


Social Media


© 2022 Tatler Asia Limited. All rights reserved.
This website uses cookies to improve your experience. See our privacy policy.